REPLIMUNE GROUP, INC. Effective Tax Rate
REPLIMUNE GROUP, INC. (REPL) reported Effective Tax Rate of 0.20% for the 12-month period ending 2026-03-31, per its 10-K filed 2026-06-29.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateContinuingOperations · last filed 2026-06-29
- REPLIMUNE GROUP, INC. effective income tax rate reconciliation, percent for the quarter ending 2024-12-31 was -0.90%.
- REPLIMUNE GROUP, INC. effective income tax rate reconciliation, percent for the quarter ending 2023-12-31 was -0.90%.
- REPLIMUNE GROUP, INC. effective income tax rate reconciliation, percent for the quarter ending 2022-12-31 was 0.00%.
- REPLIMUNE GROUP, INC. effective income tax rate reconciliation, percent for fiscal 2026 was 0.20%, a 0.00% change from fiscal 2025.
- REPLIMUNE GROUP, INC. effective income tax rate reconciliation, percent for fiscal 2025 was 0.20%, a 0.00% change from fiscal 2024.
- REPLIMUNE GROUP, INC. effective income tax rate reconciliation, percent for fiscal 2024 was 0.20%, a 0.00% change from fiscal 2023.
- REPLIMUNE GROUP, INC. effective income tax rate reconciliation, percent for fiscal 2023 was 0.20%.
| Period end | Effective Income Tax Rate Reconciliation, Percent 3 month | Effective Income Tax Rate Reconciliation, Percent 9 month | Effective Income Tax Rate Reconciliation, Percent 12 month |
|---|---|---|---|
| 2026-03-31 | 0.20% 10-K · filed 2026-06-29 | ||
| 2025-03-31 | 0.20% 10-K · filed 2026-06-29 | ||
| 2024-12-31 | -0.90% 10-Q · filed 2025-02-12 | -0.30% 10-Q · filed 2025-02-12 | |
| 2024-03-31 | 0.20% 10-K · filed 2025-05-22 | ||
| 2023-12-31 | -0.90% 10-Q · filed 2025-02-12 | -0.30% 10-Q · filed 2025-02-12 | |
| 2023-03-31 | 0.20% 10-K · filed 2024-05-16 | ||
| 2022-12-31 | 0.00% 10-Q · filed 2024-02-08 | 0.00% 10-Q · filed 2024-02-08 | |
| 2022-03-31 | 0.00% 10-K · filed 2023-05-18 | ||
| 2021-03-31 | 0.00% 10-K · filed 2022-05-19 | ||
| 2020-03-31 | 0.00% 10-K · filed 2021-05-20 | ||
| 2019-03-31 | 0.00% 10-K · filed 2020-06-03 | ||
| 2018-03-31 | 0.00% 10-K · filed 2020-06-03 | ||
| 2017-03-31 | 0.00% 10-K · filed 2019-06-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B |